It has been reported that IL-6 levels are increased in various autoimmune diseases including rheumatoid arthritis (RA), multiple sclerosis (MS) and lupus (34), and targeting IL-6 can be an effective approach in the treatment of several autoimmune diseases (35, 36). The gene discussed is IL6; the disease is myeloid sarcoma.